Monocarboxylate Transporter 4 Is a Therapeutic Target in Non-small Cell Lung Cancer with Aerobic Glycolysis Preference

Targeting metabolic reprogramming is an emerging strategy in cancer therapy. However, clinical attempts to target metabolic reprogramming have been proved to be challenging, with metabolic heterogeneity of cancer being one of many reasons that causes treatment failure. Here, we stratified non-small...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mol Ther Oncolytics
Autori principali: Kuo, Ting-Chun, Huang, Kuo-Yen, Yang, Shuenn-Chen, Wu, Sean, Chung, Wei-Chia, Chang, Yih-Leong, Hong, Tse-Ming, Wang, Shu-Ping, Chen, Hsuan-Yu, Hsiao, Tzu-Hung, Yang, Pan-Chyr
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Gene & Cell Therapy 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7364124/
https://ncbi.nlm.nih.gov/pubmed/32695876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2020.06.012
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi